To explore the molecular mechanisms that determine how MTHFD2 confers drug resistance and stem-like properties to cancer cells, we focused on AICAR, because it was the metabolite that showed the greatest increase upon MTHFD2 knockdown (Fig. 3c and Supplementary 5E). The gene discussed is MTHFD2; the disease is cancer.